Finance

Lists
Why is MMSI up 7.69%?
Dive Deeper
MMSI:NASDAQ
Merit Medical Systems Inc
$90.63
+7.69%
(+6.47) 1D
$90.63
0.00% (0.00)
After hours
Closed: Nov 4, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MMSI...
Open
$87.03
High
$91.40
Low
$85.71
Mkt. cap
5.43B
Avg. vol.
715.76K
Volume
1.39M
P/E ratio
34.02
52-wk high
$94.85
52-wk low
$59.74
EPS
$2.66
Beta
0.56
Shares outstanding
59.92M
No. of employees
8K
Open
$87.03
High
$91.40
Low
$85.71
Mkt. cap
5.43B
Avg. vol.
715.76K
Volume
1.39M
P/E ratio
34.02
52-wk high
$94.85
52-wk low
$59.74
EPS
$2.66
Beta
0.56
Shares outstanding
59.92M
No. of employees
8K
News stories
From web sources and news partners
About Merit Medical Systems Inc
CEOFred P. Lampropoulos
Employees7.5K
Founded1987
HeadquartersSouth Jordan, Utah, United States
SectorMedical device
Industry-
Websitemerit.com
Analyst ratings
Based on 9 analysts giving stock ratings to MMSI in the past 3 months
Strong buy
Buy
7
Hold
2
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for MMSI in the last 3 months.
Highest
Current $90.63
$121.00 (+33.51%)
Average
$106.67 (+17.70%)
Lowest
$90.00 (-0.70%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Petusky
Barrington
Buy
Maintained
$116.00
+28%
10/30/2026
Robbie Marcus
J.P. Morgan
Buy
Reiterated
$110.00
+21.4%
10/30/2026
Jason Bednar
Piper Sandler
Buy
Reiterated
$108.00
+19.2%
10/30/2026
Unknown Analyst
Wells Fargo
Hold
Reiterated
$92.00
+1.5%
10/30/2026
Michael Matson
Needham
Buy
Reiterated
$106.00
+17%
10/30/2026
Sam Eiber
BTIG
Buy
Maintained
$110.00
+21.4%
10/30/2026
John Young CFA
Canaccord Genuity
Buy
Reiterated
$121.00
+33.5%
10/30/2026
David Rescott
Robert W. Baird
Buy
Maintained
$107.00
+18.1%
10/30/2026
Keith Hinton
Freedom Capital Markets
Hold
Initiated
$90.00
-0.7%
10/27/2026
Travis Steed
Bank of America Securities
Hold
Maintained
-
-
07/31/2026
Jayson Bedford
Raymond James
Buy
Maintained
$100.00
+10.3%
07/31/2026
Larry Biegelsen
Wells Fargo
Hold
Reiterated
$83.00
-8.4%
07/31/2026
Last report
Oct 29, 2026
Fiscal period
Q3 2026
$1.12 / $1.04
+7.83%beat
Revenue / Est. (USD)
416.24M / 410.60M
+1.37%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
393.94M
381.88M
418.84M
416.24M
Cost of goods sold
198.58M
197.08M
203.68M
215.61M
Cost of revenue
198.58M
197.08M
203.68M
215.61M
Research and development expenses
26.54M
22.61M
25.39M
22.39M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
106.63M
118.21M
129.23M
119.51M
Operating expense
133.17M
140.82M
154.62M
141.90M
Total operating expenses
331.76M
337.90M
358.30M
357.52M
Operating income
62.18M
43.98M
60.55M
58.73M
Other non operating income
-121.00K
13.70M
1.03M
2.26M
EBT including unusual items
51.06M
53.55M
51.31M
55.78M
EBT excluding unusual items
59.05M
53.37M
51.46M
55.75M
Income tax expense
13.05M
12.55M
12.51M
13.47M
Effective tax rate
25.57%
23.44%
24.38%
24.15%
Other operating expenses
-
-
-
-
Net income
38.01M
41.00M
38.80M
42.31M
Net profit margin
9.65%
10.74%
9.26%
10.16%
Earnings per share
1.04
0.94
1.19
1.12
Interest and investment income
3.90M
3.90M
3.75M
4.13M
Interest expense
-6.36M
-6.53M
-12.12M
-7.33M
Net interest expenses
-2.46M
-2.63M
-8.37M
-3.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
93.72M
74.47M
91.59M
90.57M
Gain or loss from assets sale
1.76M
-12.44M
344.00K
648.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps